Clinical Trial Update: Density of Neurons in the Stomach and Prognosis of Gastric Adenocarcinoma [NA]

View source ↗

Summary

The clinical trial NCT01821196 evaluating neuronal density in the stomach and prognosis of gastric adenocarcinoma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Adenocarcinoma
• Stomach Neoplasms

Snippet

Sponsor: St. Olavs Hospital | Conditions: Stomach Neoplasms | NA | Status: WITHDRAWN